Dr. Daniel Kolarich is a research leader at the Institute for Glycomics, Griffith University, Queensland, Australia. His group is using Mass Spectrometry based techniques to understand the role of cell surface glycoconjugates, such as glycoproteins and glycolipids, in cell communication, cell signalling, host-pathogen interactions, and diseases such as cancer. Specific research interests include analytical tool development for glycomics and glycoproteomics, Vertebrata phyloglycomics, erythropoiesis, blood products, and stem cell biology, as well as applying glycomics and glycoproteomics to understand better the role of glycoconjugates in cancer and infectious diseases.
Originally from Vienna, Austria, he had the chance to learn from great mentors and scientists, from Vienna, where he received his education and Ph.D. via Sydney at Macquarie University and Berlin at the Max-Planck-Institute of Colloids and Interfaces before he finally landed at the Gold Coast to join the Institute for Glycomics. He has published over 140 peer-reviewed articles, is the vice president of the Australian Glycoscience Society, and is dedicated to promoting and integrating glycosciences.